Precision diagnostics and medicine market is projected to reach USD 345.75 billion by 2035, while US personalized medicine is set to surpass US$ 307 billion by 2033. AI, single-cell analysis, and clinical laboratory markets also show strong growth.
The global mRNA and next-generation vaccine platforms market is expected to grow from $39.69 billion in 2025 to $82.61 billion by 2030 at a 15.8% CAGR, driven by personalized medicine demand and infectious disease applications, while safety concerns and regulatory scrutiny continue.
The drug development services market is projected to reach $31.5 billion in 2026, growing at 12.2% CAGR, while AI-designed drugs enter pivotal Phase III trials that will determine whether the technology can improve clinical success rates beyond the industry's persistent 90% failure rate.
